SCN5A and ovarian cancer: In our study, the ovarian cancer cells were treated with lidocaine; at its concentration of 5 mM, the proliferation and metastasis potential of ovarian cancer was significantly suppressed and its effects, at least in part, was through its inhibition of NaV1.5.